Material and Method
The first group consisted of epileptic patients, whose electroencephalographic characteristics were known from earlier recordings. They were selected both from hospital wards and an out-patient clinic and were grouped as follows:-(a) Patients with persistently abnormal inter-seizure recordings (20 patients, 14 male, six female, ages 5 to 62 years, mean 30 years); (b) patients with fairly normal inter-seizure recordings (20 patients, 13 male, seven female, ages 16 to 58 years, mean 32 years).
The second group was a control group of patients from hospital wards and from out-patient clinics excluding any cases with seizures or head injuries, or who had been subjected to brain surgery, insulin coma treatment, electric convulsive treatment for at least four months, or to whom " tranquillizing" drugs had been administered. This group consisted of patients diagnosed as psychoneurotic, unstable personality and early schizophrenia in the younger age group, psychoneurosis and paraphrenia in the middle age group, and chronic schizophrenia and high grade mental defect in the older age group (20 patients, 15 male, five female, ages 18 to 65 years, mean 37-6 years). In most of these cases at least one E.E.G. had been taken previously.
One millilitre of a commercial chlorpromazine solution containing 25 mg. of the drug was diluted to 10 ml. with normal saline. Of this dilution 1 ml. was injected intravenously every 1 to 1I minutes up to a maximum of 0 3 to 0-5 mg. per kg. body weight. Immediately before the injection a routine E.E.G., including overbreathing and photic stimulation, was taken and the recording continued while the injection was given. Normal Controls.-About 15 minutes after the response, usually around 2 to 3 c./sec., a higher beginning of the injection of chlorpromazine when proportion of the lower frequencies (4 to 5 c./sec.) the patient appears to get drowsy the E.E.G. shows in the theta range, and a more paroxysmal and a general decrease in amplitude, most conspicuously bilaterally symmetrical appearance of these changes. in the posterior parts. The dominant frequency, There was one exception in a man of 36 who showed i.e., usually the alpha, slows down by 1 to 2 c./sec. after 15 to 16 minutes bilateral runs of low-amplitude Theta activity of 5 to 7 c./sec. becomes more splkes in the posterior parietal regions. prominent and spreads from the posterior parts to the intermastoid plane and sometimes further forEpileptic Patients in Group (a). -Table II shows ward. At the same time muscle spike artefact usually in more detail significant abnormal features in this decreases. Posterior sharp waves of about 250 to group seen before the injection of chlorpromazine 300 m.sec. duration, resembling lambda waves, are either in the resting recording or after activation often seen after about 20 to 30 minutes. Occasionally by overbreathing or photic stimulation. Among No convulsive seizures were observed during the investigation in any of the 60 patients. Alterations of consciousness occurred, as would be expected, in a child of 10 suffering from petit mal during the prolonged spike-and-wave discharges, and apparently in the patient C. G. (Fig. 1) Chlorpromazine caused a fall in the systolic blood pressure by about 20 mm. Hg in the recumbent position, and patients were encouraged to lie on the examination couch for about 30 minutes to avoid postural hypotensive faints. In some cases the face was pale and the patients complained of sickness 15 to 20 minutes after the start of the injection. No relation was found between circulatory changes and changes in the E.E.G.
Discussion
The investigations show that intravenous chlorpromazine in doses of 0 3 to 0 5 mg. per kg. body weight can cause increased paroxysmal and/or hypersynchronous activity in the E.E.G. of epileptic patients. The changes after the injection are essentially similar to those seen in this series of patients after activation by overbreathing and photic stimulation but they are often more obvious and of longer duration. They also resemble the changes observed in barbiturate-induced sleep and during insulin hypoglycaemia in the few patients where these methods had been used before chlorpromazine. The known abnormalities were enhanced but new abnormal features did not appear. The activation was more successful in unstable than in stable recordings, i.e., in patients with greater numbers of seizures more resistant to treatment. These findings are therefore similar to those described and illustrated by Bente and Itil (1954) , Mayr and Lechner (1954 ), Szatmari (1956 ), and Turner et al. (1956 . Lyberi and Last (1956) observed activation of the E.E.G. in their cW,_es, which included a high proportion of patients-with gross anatomical cerebral lesions, under very c-2nilar conditions. Investigations on animals using a -riteria the convulsive threshold for drugs and electric current are difficult to compare with each other and with clinical findings on account of the use of different animals and widely different dosage. The comparatively small doses used by Balestrieri (1955) and by Balestrieri and Franceschini (1956) 
